Restricted stock grant increases Concentrix (NASDAQ: CNXC) director stake

Rhea-AI Filing Summary

OGUT BILGE reported acquisition or exercise transactions in this Form 4 filing.

Concentrix Corp director Bilge Ogut received 7,701 shares of common stock as a restricted stock unit award. The grant was made at no cash cost to the director and represents equity-based compensation rather than an open-market purchase or sale.

According to the terms, these restricted stock units vest in full on the earlier of the one-year anniversary of the grant date or the date of Concentrix’s 2027 Annual Meeting of Stockholders. After this award, Ogut holds 7,701 shares directly, aligning personal ownership with shareholder interests through time-based vesting.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider OGUT BILGE

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	7,701	$0.00	--

Holdings After Transaction: Common Stock — 7,701 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

OGUT BILGE

(Last) (First) (Middle)

39899 BALENTINE DRIVE

SUITE 235

(Street)

NEWARK CALIFORNIA 94560

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Concentrix Corp [ CNXC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/25/2026		A(1)		7,701	A	$0	7,701	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of restricted stock units awarded under the 2020 Stock Incentive Plan. The restricted stock units vest in full on the earlier of (x) the one-year anniversary of the date of grant and (y) the date of the Issuer's 2027 Annual Meeting of Stockholders.

Remarks:

	/s/ Andrew Farwig, Attorney-in-Fact	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Concentrix (CNXC) director Bilge Ogut report in this Form 4?

Bilge Ogut reported receiving an award of 7,701 shares of Concentrix common stock as restricted stock units. The award is equity compensation, not an open-market transaction, and brings Ogut’s directly held stake to 7,701 shares following the grant.

Is the Concentrix (CNXC) Form 4 a stock purchase or a compensation grant?

The Form 4 reflects a compensation grant, not a stock market purchase. Bilge Ogut received 7,701 restricted stock units at no cash cost under the 2020 Stock Incentive Plan as part of director equity compensation, rather than buying shares on the open market.

When do Bilge Ogut’s Concentrix (CNXC) restricted stock units vest?

The 7,701 restricted stock units vest in full on the earlier of two dates: the one-year anniversary of the grant date or the date of Concentrix’s 2027 Annual Meeting of Stockholders. Vesting must occur before the award fully converts into unrestricted shares.

How many Concentrix (CNXC) shares does Bilge Ogut own after this transaction?

After the reported transaction, Bilge Ogut beneficially owns 7,701 shares of Concentrix common stock directly. This entire position reflects the newly granted restricted stock units, which are subject to vesting conditions before becoming fully unrestricted shares.

Was there any sale of Concentrix (CNXC) shares in this Form 4 filing?

No sale occurred in this filing. The Form 4 shows only an acquisition via a grant of 7,701 restricted stock units to director Bilge Ogut. There are no reported dispositions, tax withholdings, or open-market sales associated with this particular transaction.